
NAMS Market Capitalization Overview
Market Cap: $3.80B as of Jan 5, 2026
$3.80B
$201.84M (5.05%)past month
As of Jan 5, 2026, NAMS has a market capitalization of $3.80B. Over the past 30 days, its market cap has decreased by -11.13%, while in the last 12 months, it has decreased by -4.56%.
Market capitalization represents the total value of Newamsterdam Pharma Co NV as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NAMS Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NAMS helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Newamsterdam Pharma Co NV as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NAMS Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NAMS helps investors assess the company's size and compare it with competitors for better investment decisions.
NAMS Market Cap & Key Trends
See Newamsterdam Pharma Co NV’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in NAMS
Order type
Buy in
Order amount
Est. shares
0 shares
NAMS Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $4.50B | +7.78% |
| Nov 3, 2025 | $4.17B | +26.02% |
| Oct 1, 2025 | $3.31B | +19.20% |
| Sep 2, 2025 | $2.78B | +16.11% |
| Aug 1, 2025 | $2.39B | +16.79% |
| Jul 1, 2025 | $2.05B | -3.75% |
| Jun 2, 2025 | $2.13B | -3.38% |
| May 1, 2025 | $2.20B | +8.98% |
| Apr 1, 2025 | $2.02B | -9.32% |
| Mar 3, 2025 | $2.23B | -2.45% |
| Feb 3, 2025 | $2.29B | -17.72% |
| Jan 2, 2025 | $2.78B | +52.85% |
NAMS End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $3.80B | -4.56% |
| 2025 | $3.98B | +44.88% |
| 2024 | $2.75B | +198.58% |
| 2023 | $919.57M | +375.26% |
| 2022 | $193.49M | +11.79% |
| 2021 | $173.08M | — |
FAQs About Newamsterdam Pharma Co NV (NAMS) Market Cap
As of Jan 5, 2026, the market capitalization of NAMS is $3.80B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Newamsterdam Pharma Co NV’s market capitalization has decreased by -5.05%, changing from $3.99B to $3.80B as of Jan 5, 2026.
In the last 3 months, Newamsterdam Pharma Co NV’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Newamsterdam Pharma Co NV’s market capitalization increased from $2.75B in January to $3.98B in December, reflecting a 44.88% change.
In the past five years, NAMS has had a compound annual growth rate (CAGR) of 87.19% in market capitalization. This means its market cap has grown at an average rate of 87.19% per year.